Medical Xpress news

Medical Xpress / A failed fragile X syndrome drug can reduce cocaine use, clinical trial finds

A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has found that the drug mavoglurant can reduce use in people with cocaine use disorder. In their study, ...

Apr 3, 2025 in Medications
Medical Xpress / Hitting the target: Imaging reveals psilocybin's neural odyssey

Psilocybin is the active ingredient that gives so-called "magic mushrooms" their hallucinogenic kick. It also has a therapeutic potential for treating depression.

Apr 3, 2025 in Psychology & Psychiatry
Medical Xpress / Ultrasound reveals capillaries and cells in living organs

Researchers from the University of Technology Delft, the Netherlands Institute for Neuroscience and Caltech have developed a microscopy technique based on ultrasound to reveal capillaries and cells across living organs—something ...

Apr 3, 2025 in Radiology & Imaging
Medical Xpress / Gene editing reprograms colon cells to combat short bowel syndrome

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine. In a preclinical study, Weill Cornell Medicine investigators showed that the technique reversed the ...

Apr 3, 2025 in Genetics
Medical Xpress / Virtual reality research explores curiosity and spatial memory

Virtual reality reveals that curiosity is key in shaping our spatial memory and mental map formation, finds new research by Cardiff University and Royal Holloway, University of London.

Apr 3, 2025 in Psychology & Psychiatry
Medical Xpress / Beagle study reveals genetic link to face-processing deficits in autism

A new study has revealed that Beagle dogs carrying mutations in the Shank3 gene—a high-risk gene for autism spectrum disorder (ASD)—exhibit face-processing abnormalities similar to those observed in human ASD patients.

Apr 3, 2025 in Genetics
Medical Xpress / Parkinson's protein clumps in heart nerves could offer new treatment path

Parkinson's doesn't just affect movement and the brain—it may also impact the heart, according to new research from the University of Surrey. Scientists from Surrey's School of Veterinary Medicine suggest that targeting ...

Apr 3, 2025 in Neuroscience
Medical Xpress / Key differences between visual and memory-led Alzheimer's discovered

Differences in the distribution of certain proteins and markers in the brain may explain why some people first experience vision changes instead of memory loss in Alzheimer's disease, finds a new study by UCL researchers.

Apr 3, 2025 in Neuroscience
Medical Xpress / A new targeted approach could protect neurons against degeneration

Neurodegenerative conditions such as Parkinson's disease and Alzheimer's involve progressive neuronal loss due to disease-induced damage. An enzyme known as dual leucine-zipper kinase (DLK) plays a key role in this process, ...

Apr 3, 2025 in Neuroscience
Medical Xpress / Tiny peptide sequence rivals steroid cream in psoriasis treatment

Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis when applied topically in an emollient cream.

Apr 3, 2025 in Medical research
Medical Xpress / Blood clots on a chip: New model could improve thromboinflammation treatment

Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.

Apr 3, 2025 in Cardiology
Medical Xpress / AI-powered database spotlights medication risks to improve drug safety

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in the United States and a medical issue costing more than $500 billion annually.

Apr 3, 2025 in Medications